Endometrial mixed mullerian tumor with heterologous elements following tamoxifen therapy for breast cancer: a case report and literature review

By Kaleli S.   Calay Z.   Altinok T.   Kosebay D.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 101, Iss. 2, 2002-03 ,pp. : 204-208

Elsevier

Access to resources Recommend Favorite

Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer

By Friedrich M.   Villena-Heinsen C.   Mink D.   Bonkhoff H.   Schmidt W.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 82, Iss. 1, 1999-01 ,pp. : 85-87

Elsevier

Access to resources Recommend Favorite

Diagnostic accuracy of sonohysterography in the evaluation of uterine cavities in tamoxifen administered asymptomatic postmenopausal breast cancer patients with endometrial thickness ≥5 mm

By Inal M.   Yildirim Y.   Incebiyik A.   Sanci M.   Ispahi C.  

Gynecological Surgery, Vol. 3, Iss. 4, 2006-12 ,pp. : 271-274

Springer Publishing Company

Access to resources Recommend Favorite

Is tamoxifen associated with high-risk endometrial carcinomas? A retrospective case series of 196 women with endometrial cancer

By Rieck GC   Freites ON   Williams S  

Journal of Obstetrics & Gynaecology, Vol. 25, Iss. 1, 2005-01 ,pp. : 39-41

Informa Healthcare

Access to resources Recommend Favorite

Ultrasonographic appearance of endometrium in postmenopausal breast cancer patients receiving tamoxifen

By Bese T.   Kosebay D.   Demirkiran F.   Arvas M.   Bese N.   Mandel N.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 67, Iss. 2, 1996-08 ,pp. : 157-162

Elsevier

Access to resources Recommend Favorite